Sign & Support the campaign for Research & Trials in ‘Low Dose Naltrexone for Multiple Sclerosis’
This petition is in support of the campaign to get Low Dose Naltrexone (LDN) into clinical trials. Many drugs used for MS on a daily basis have not been in clinical trials and yet Doctors still prescribe them to MS patients.

Some drugs used in the treatment of MS have serious side effects. Low Dose Naltrexone is prescribed at such a low dose of 3 – 4.5 mg daily that there is absolutely no harm in using it. Many people have found their progression to stop or at least slow down immensely while taking LDN. Unfortunately though LDN is still rarely prescribed, therefore the sooner we get trials underway the better.

Many people from around the world are trying to get their doctors to prescribe LDN but very few are lucky enough to find a good doctor who will help. Dr. Bihari in New York and Dr. Lawrence in Wales are under alot of pressure trying to help as many patients they can. At present they have to put many on a waiting list because there are little other doctors helping them by prescribing this drug.

Your help is needed right now! Please sign this petition today and send it to as many people with as possible, together we can make a difference.

Our team of campaigners for LDN hope to reach our goal of 100,000 signatures with your help. No matter where you live, you are important to us as we are campaigning for EVERYBODY WITH MULTIPLE SCLEROSIS. We will then send the results to politicians in all corresponding countries.

1 Comment

robbiesmi · August 26, 2007 at 3:06 pm

I would love to see more study, BUT hate to think this will fall in the hands of the Pharmaceutical companies, thus adding astronomical price to the now affordable product. My Dr will not fill the Rx as yet because the ‘hasn’t been enough study’ I beg to differ, there seems to be a lot of grass roots study going on and I think the grass roots approach is the best before the FDA gets it’s hands on a what looks like a break through for MS at least, as this is the area of my immediate concern.

Leave a Reply